The Phosphatidylinositol 3-kinase/Akt Signaling Pathway in Neuroendocrine Tumors
- PMID: 27990410
- PMCID: PMC5157925
The Phosphatidylinositol 3-kinase/Akt Signaling Pathway in Neuroendocrine Tumors
Abstract
The phosphatidylinositol 3-kinase (PI3K)-Akt pathway is often aberrantly activated in neuroendocrine-derived cancers. Therefore, selectively targeting this pathway using small-molecule inhibitors may reduce neuroendocrine tumor burden, potentiate adjunct therapies, and achieve symptomatic control for patients with hormonally active and inoperable disease. Here, we discuss the role of the PI3K-Akt pathway in the malignant transformation of neuroendocrine tumors, specifically carcinoids and small cell lung cancers. The collective findings presented in this review propose that selective targeting of the PI3K-Akt pathway may mitigate neuroendocrine tumor progression, thus offering a viable therapeutic approach for managing systemic disease.
Keywords: ASCL1; Akt; Carcinoids; Chromogranin A; NE Tumors; Notch pathway; Raf-1 pathway; SCLC.
Similar articles
-
Sonic hedgehog signaling pathway promotes INSM1 transcription factor in neuroendocrine lung cancer.Cell Signal. 2018 Jun;46:83-91. doi: 10.1016/j.cellsig.2018.02.014. Epub 2018 Mar 1. Cell Signal. 2018. PMID: 29501727
-
Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.Biochim Biophys Acta. 2012 Dec;1826(2):255-71. doi: 10.1016/j.bbcan.2012.05.001. Epub 2012 May 10. Biochim Biophys Acta. 2012. PMID: 22579738 Review.
-
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.Adv Enzyme Regul. 2006;46:249-79. doi: 10.1016/j.advenzreg.2006.01.004. Epub 2006 Jul 18. Adv Enzyme Regul. 2006. PMID: 16854453
-
Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation.Cancer Discov. 2021 Dec 1;11(12):3028-3047. doi: 10.1158/2159-8290.CD-20-1863. Cancer Discov. 2021. PMID: 34155000 Free PMC article.
-
Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: an emerging treatment strategy for squamous cell lung carcinoma.Cancer Treat Rev. 2014 Sep;40(8):980-9. doi: 10.1016/j.ctrv.2014.06.006. Epub 2014 Jul 3. Cancer Treat Rev. 2014. PMID: 25037117 Review.
Cited by
-
Extracellular Vesicles for Clinical Diagnostics: From Bulk Measurements to Single-Vesicle Analysis.ACS Nano. 2025 Aug 12;19(31):28021-28109. doi: 10.1021/acsnano.5c00706. Epub 2025 Jul 28. ACS Nano. 2025. PMID: 40720603 Free PMC article. Review.
-
Neuroendocrine phenotype alteration and growth suppression through apoptosis by MK-2206, an allosteric inhibitor of AKT, in carcinoid cell lines in vitro.Anticancer Drugs. 2013 Jan;24(1):66-72. doi: 10.1097/CAD.0b013e3283584f75. Anticancer Drugs. 2013. PMID: 23147412 Free PMC article.
References
-
- Sippel R, Carpenter J, Kunnimalaiyaan M, Chen H. The role of human achaete-scute homolog-1 in medullary thyroid cancer cells. Surgery. 2003;134:866–871. discussion 871-863. [PubMed: 14668716] - PubMed
-
- Van Gompel J, Sippel R, Warner T, Chen H. Gastrointestinal carcinoid tumors: factors that predict outcome. World J Surg. 2004;28:387–392. [PubMed: 14994141] - PubMed
-
- Sippel R, Carpenter J, Kunnimalaiyaan M, Lagerholm S, Chen H. Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells. Am J Physiol Gastrointest Liver Physiol. 2003;285:G245–G254. [PubMed: 12851216] - PubMed
-
- Kunnimalaiyaan M, Ndiaye M, Chen H. Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002. Surgery. 2006;140:1009–1014. discussion 1014-1005. [PubMed: 17188151] - PubMed
-
- Lal A, Chen H. Treatment of advanced carcinoid tumors. Curr Opin Oncol. 2006;18:9–15. [PubMed: 16357558] - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous